This weeks RGH Bulletin looks at
the Clinical issues with the newer
oral anti-coagulants.
The review summarizes key issues
around the novel anticoagulants
now listed on the PBS - and
interestingly concludes that “none
of these novel anticoagulants have
been demonstrated to have clear
advantages relative to warfarin or
low molecular weight heparin.
“People who are well controlled
on warfarin will probably not
benefit from changing to NOAC,” it
adds - CLICK HERE to view.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Sep 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Sep 13
PHARMACISTS in Western Australia will be able to resupply oral contraceptives as part of a new pilot program, as Queensland clocks up over 10,000 visits by women seeking in-pharmacy treatments for uncomplicated urinary tract infections (UTI).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.